Prostate cancer: new class of drug that interferes with AR signalling.

Clyne, Melanie

Prostate cancer: new class of drug that interferes with AR signalling. [electronic resource] - Nature reviews. Urology Aug 2013 - 432 p. digital

Publication Type: Journal Article; Comment

1759-4820

10.1038/nrurol.2013.138 doi


Animals
Co-Repressor Proteins--metabolism
Humans
Male
Peptidomimetics--pharmacology
Prostatic Neoplasms--metabolism
Receptors, Androgen--metabolism
Transcription Factors--metabolism